Document is current
Any future updates will be listed below
-
Authors
Kuttanamkuzhi, Abhijith http://orcid.org/0000-0003-3643-0291
Panda, Debiprasad
Malaviya, Radhika
Gaidhani, Gautami
Lahiri, Mayurika http://orcid.org/0000-0001-9456-4920
-
Funding
Funding for this research was provided by:
Science and Engineering Research Board (EMR/2016/001974)
- License Information
-
More Information
Article History
Received: 23 September 2022
Accepted: 20 April 2023
First Online: 25 April 2023
Declarations
:
: Ethics approval from Institutional Human Ethics Committee (IHEC) was obtained for using patient paraffin-embedded tissue blocks in this study (IHEC/Admin/2021/012). Written informed consent was obtained by Prashanti Cancer Care Mission, Pune from all patients, and the study was conducted in accordance with the Declaration of Helsinki, institutional guidelines, and all local, state and national regulations. For preparing Api5 OE MCF10A cells, Api5 KD MCF10AT1 and Api5 KD MCF10CA1a cells Institutional Biosafety Committee (IBSC) clearance was approved by the institute. The in vivo tumorigenicity studies were approved by the Institutional Animal Ethics Committee (IAEC) (IAEC/2018_02/010 and IISER_Pune/IAEC/2021_01/06).
: N/A.
: The authors declare no competing interests.
